drugset / Trial / NCT06613243

Different Doses of Dexmedetomidine Combined With Esketamine in Women Undergoing Cesarean Delivery

NCT06613243

Phase 4 Completed 120 enrolled Peking University First Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Esketamine is a commonly used analgesic during cesarean delivery, but may produce transient neuropsychiatric symptoms. Dexmedetomidine has both sedative and analgesic effects. When used in combination with esketamine, dexmedetomidine can reduce esketamine related neuropsychiatric effects after general anesthesia. The investigator speculate that combining low-dose dexmedetomidine with esketamine may also reduce neuropsychiatric adverse effects of esketamine in women undergoing cesarean section. This pilot trial is designed to determine the minimum dose of dexmedetomidine that can effectively prevent neuropsychiatric side effects of antidepressive dose esketamine (0.2mg/kg) in women undergoing cesarean delivery.

Timeline

Start
2024-10-08
Primary completion
2024-12-02
Completion
2024-12-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.1 ug/kg
Subject Dexmedetomidine Other / unclassified 0.15 ug/kg
Subject Dexmedetomidine Other / unclassified 0.2 ug/kg
Comparator Esketamine Other / unclassified 0.2 mg/kg

Indications

No indication recorded.